On May 30, 2018 NexImmune, an emerging leader in the field of antigen-directed immunotherapy, reported that the company will be participating in the following conferences (Press release, NexImmune, MAY 30, 2018, View Source [SID1234554956]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies 2018 Healthcare Conference in New York City. Scott Carmer, Chief Executive Officer will be presenting a company update;
2018 BIO International Convention in Boston. Kristi Jones, Chief Operating Officer, will attend and host 1×1 meetings and partnering discussions.